Item request has been placed! ×
Item request cannot be made. ×
loading  Processing Request

Liver Fat Fraction and Machine Learning Improve Steatohepatitis Diagnosis in Liver Transplant Patients

Item request has been placed! ×
Item request cannot be made. ×
loading   Processing Request
  • معلومة اضافية
    • بيانات النشر:
      Zenodo
    • الموضوع:
      2025
    • Collection:
      Zenodo
    • نبذة مختصرة :
      This study investigates the diagnostic accuracy of liver fat fraction (FF) and other biomarkers in differentiating metabolic dysfunction-associated steatohepatitis (MASH) from non-MASH conditions in a cohort of 127 liver transplant patients using H-1 MRS and machine learning techniques. Receiver operating characteristic analysis identified FF as the most significant predictor, achieving an area under the curve (AUC) > 0.96 for distinguishing MASH from non-steatosis and non-MASH metabolic dysfunction-associated steatotic liver disease (MASLD). Secondary biomarkers, including insulinemia and elastography, showed moderate discriminatory power (AUC = 0.7-0.8) and contributed to refining classification decisions within a decision tree model. The decision tree analysis, validated with 10-fold cross-validation and independent testing, demonstrated robust sensitivity and specificity, with FF contributing 60%-70% to decision-making. Secondary splits, such as insulinemia (similar to 16.21 mu IU/mL) and elastography (similar to 8 kPa), provided additional discriminatory power, particularly in cases with borderline FF values. Non-significant biomarkers, such as waist circumference and signals of diallylic protons resonating at 2.8 ppm, were excluded due to low discriminatory performance (AUC < 0.7). Compared to the general population (similar to 5.8% prevalence), MASH was significantly more common in liver transplant recipients (similar to 30%-50%). In patients with FF > 5.3%, the positive predictive value (PPV) for MASH ranged from 88% to 97%, more than twice the PPV observed in the general population (approximately 60%). These findings align with existing literature validating MRI-derived proton density fat fraction as a reliable biomarker for hepatic steatosis. However, liver fat percentage alone is insufficient for MASH diagnosis. Secondary biomarkers, particularly insulinemia and elastography, enhanced classification accuracy near the FF threshold of 5.3%. This multiparametric approach significantly improves ...
    • ISSN:
      0952-3480
      1099-1492
    • Relation:
      https://zenodo.org/communities/ikem/; https://zenodo.org/communities/cardia/; https://zenodo.org/records/15739220; oai:zenodo.org:15739220; https://doi.org/10.1002/nbm.70077
    • الرقم المعرف:
      10.1002/nbm.70077
    • الدخول الالكتروني :
      https://doi.org/10.1002/nbm.70077
      https://zenodo.org/records/15739220
    • Rights:
      Creative Commons Attribution 4.0 International ; cc-by-4.0 ; https://creativecommons.org/licenses/by/4.0/legalcode
    • الرقم المعرف:
      edsbas.11FB13FD